CERO
Price
$7.67
Change
-$0.08 (-1.03%)
Updated
Aug 1, 04:59 PM (EDT)
Capitalization
9.32M
UTHR
Price
$294.28
Change
+$19.58 (+7.13%)
Updated
Aug 1, 04:59 PM (EDT)
Capitalization
13.31B
89 days until earnings call
Interact to see
Advertisement

CERO vs UTHR

Header iconCERO vs UTHR Comparison
Open Charts CERO vs UTHRBanner chart's image
CERO Therapeutics Holdings
Price$7.67
Change-$0.08 (-1.03%)
VolumeN/A
Capitalization9.32M
United Therapeutics
Price$294.28
Change+$19.58 (+7.13%)
Volume$6.55K
Capitalization13.31B
CERO vs UTHR Comparison Chart in %
Loading...
CERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CERO vs. UTHR commentary
Aug 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERO is a Hold and UTHR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 02, 2025
Stock price -- (CERO: $7.80 vs. UTHR: $274.70)
Brand notoriety: CERO and UTHR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CERO: 15% vs. UTHR: 117%
Market capitalization -- CERO: $9.32M vs. UTHR: $12.42B
CERO [@Biotechnology] is valued at $9.32M. UTHR’s [@Biotechnology] market capitalization is $12.42B. The market cap for tickers in the [@Biotechnology] industry ranges from $223.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERO’s FA Score shows that 1 FA rating(s) are green whileUTHR’s FA Score has 0 green FA rating(s).

  • CERO’s FA Score: 1 green, 4 red.
  • UTHR’s FA Score: 0 green, 5 red.
According to our system of comparison, UTHR is a better buy in the long-term than CERO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERO’s TA Score shows that 3 TA indicator(s) are bullish while UTHR’s TA Score has 5 bullish TA indicator(s).

  • CERO’s TA Score: 3 bullish, 4 bearish.
  • UTHR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, UTHR is a better buy in the short-term than CERO.

Price Growth

CERO (@Biotechnology) experienced а +5.12% price change this week, while UTHR (@Biotechnology) price change was -10.35% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.32%. For the same industry, the average monthly price growth was +16.82%, and the average quarterly price growth was +37.20%.

Reported Earning Dates

CERO is expected to report earnings on Apr 15, 2025.

UTHR is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Biotechnology (+1.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
UTHR($13.3B) has a higher market cap than CERO($9.32M). UTHR YTD gains are higher at: -22.146 vs. CERO (-93.500). UTHR has higher annual earnings (EBITDA): 1.68B vs. CERO (-8.49M). UTHR has more cash in the bank: 3.32B vs. CERO (5.2M). CERO has less debt than UTHR: CERO (1.37M) vs UTHR (200M). UTHR has higher revenues than CERO: UTHR (2.99B) vs CERO (0).
CEROUTHRCERO / UTHR
Capitalization9.32M13.3B0%
EBITDA-8.49M1.68B-1%
Gain YTD-93.500-22.146422%
P/E RatioN/A11.48-
Revenue02.99B-
Total Cash5.2M3.32B0%
Total Debt1.37M200M1%
FUNDAMENTALS RATINGS
UTHR: Fundamental Ratings
UTHR
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
37
SMR RATING
1..100
45
PRICE GROWTH RATING
1..100
78
P/E GROWTH RATING
1..100
80
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CEROUTHR
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
47%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
37%
Bearish Trend 2 days ago
58%
MACD
ODDS (%)
Bearish Trend 2 days ago
27%
Bearish Trend 2 days ago
47%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
31%
Bearish Trend 2 days ago
56%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
52%
Advances
ODDS (%)
Bullish Trend 15 days ago
56%
Bullish Trend 9 days ago
71%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 2 days ago
59%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
63%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
CERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
UTHR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
MYY18.560.33
+1.81%
ProShares Short MidCap400
DXUV55.43-0.21
-0.38%
Dimensional US Vector Equity ETF
GEM37.42-0.23
-0.61%
Goldman Sachs ActiveBeta® EMkts Eq ETF
RSPS30.14-0.38
-1.24%
Invesco S&P 500® Eql Wt Cnsm Stapl ETF
ASEA16.31-0.30
-1.79%
Global X FTSE Southeast Asia ETF

CERO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CERO has been loosely correlated with UNCY. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CERO jumps, then UNCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERO
1D Price
Change %
CERO100%
+11.43%
UNCY - CERO
37%
Loosely correlated
-1.81%
UTHR - CERO
34%
Loosely correlated
-2.57%
ACXP - CERO
34%
Loosely correlated
-1.15%
VERV - CERO
32%
Poorly correlated
N/A
BRTX - CERO
30%
Poorly correlated
-0.68%
More

UTHR and

Correlation & Price change

A.I.dvisor indicates that over the last year, UTHR has been loosely correlated with DAWN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if UTHR jumps, then DAWN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To UTHR
1D Price
Change %
UTHR100%
-2.57%
DAWN - UTHR
40%
Loosely correlated
-2.47%
MNKD - UTHR
39%
Loosely correlated
-2.45%
GERN - UTHR
39%
Loosely correlated
+4.55%
CBIO - UTHR
36%
Loosely correlated
-1.67%
INSM - UTHR
35%
Loosely correlated
+2.04%
More